• to reduce the chance of major cardiovascular (coronary heart and blood vessel) issues in adults with variety two diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss pill in Might but remains hoping for the slice of the industry with MariTide, a regular monthly injection that is cert